Escalon Medical Corp
ESMC
ESMC was delisted on the 17th of November, 2016.
12 hedge funds and large institutions have $1.34M invested in Escalon Medical Corp in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
50% more capital invested
Capital invested by funds: $893K → $1.34M (+$448K)
50% more funds holding
Funds holding: 8 → 12 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$105K |
| 2 |
Bank of New York Mellon
New York
|
+$25.9K |
| 3 |
Morgan Stanley
New York
|
+$1.62K |
| 4 |
Renaissance Technologies
New York
|
+$485 |
| 5 |
SSG
Summit Securities Group
New York
|
+$81 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
-$4K |
ESMC Hedge Fund Activity: Q4 2013 in Review
12 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Escalon Medical Corp (ESMC) for Q4 2013, worth a combined $1.34M — up 50% from $893K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ESMC positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $105K. The largest seller was UBS, exiting entirely with an estimated $4K sold.
- 12 institutional investors held Escalon Medical Corp (ESMC) as of Q4 2013, up from 8 in Q3 2013.
- Funds reported $1.34M of Escalon Medical Corp stock for Q4 2013, up 50% quarter-over-quarter.
- 5 funds opened new Escalon Medical Corp positions in Q4 2013 and 1 closed out, a net change of +4 holders.
- The largest Escalon Medical Corp buyer in Q4 2013 was Vanguard Group, an estimated $105K added.
- The largest Escalon Medical Corp seller in Q4 2013 was UBS, an estimated $4K sold.
Based on aggregated 13F filings for Q4 2013.